← back to search

Qiuran Xu

Second Military Medical University · CN
🔎 Find collaborators in Cancer Research · Molecular Biology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer research, Metastasis, Gene knockdown, Medicine, Hepatocellular carcinoma, and Biology.
h-index
citations
761
works
8
NIH funding
primary concept
email

Recent publications

Postoperative morbidity adversely impacts long-term oncologic prognosis following hepatectomy for hepatocellular carcinoma: A multicenter observational study
European Journal of Surgical Oncology 2021cited by 16position: middledoi
Long-Term Surgical Outcomes of Liver Resection for Hepatocellular Carcinoma in Patients With HBV and HCV Co-Infection: A Multicenter Observational Study
Frontiers in Oncology 2021cited by 9position: middledoi
Long-term surgical outcomes of liver resection for hepatocellular carcinoma in patients with hepatitis B virus and hepatitis C virus co-infection: A multicenter observational study
Annals of Hepato-Biliary-Pancreatic Surgery 2021cited by 1position: middledoi
SHMT1 inhibits the metastasis of HCC by repressing NOX1-mediated ROS production
Journal of Experimental & Clinical Cancer Research 2019cited by 80position: middledoi
Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway
Oncogene 2018cited by 121position: middledoi
MicroRNA-876-5p inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by targeting BCL6 corepressor like 1
Biomedicine & Pharmacotherapy 2018cited by 57position: firstdoi
HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma
Molecular Cancer 2017cited by 307position: firstdoi
MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway
Molecular Cancer 2017cited by 170position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Kangsheng Tu · Second Military Medical University5 papers (2017–2019)Yufeng Wang · Johns Hopkins Medicine4 papers (2017–2018)Zhikui Liu · Soochow University3 papers (2017–2018)Yingjian Liang · Harbin Medical University3 papers (2021–2021)Zhenyu Zhou · Nanchang University3 papers (2017–2018)Han Wu · Peking University3 papers (2021–2021)Wei‐Min Gu · Hebei University of Engineering3 papers (2021–2021)Chengwu Zhang · Qinghai University3 papers (2019–2021) · 3 papers (2021–2021)Yong‐Kang Diao · Second Military Medical University3 papers (2021–2021)Changwei Dou · Xi'an Jiaotong University3 papers (2017–2019)Hang‐Dong Jia · Second Military Medical University3 papers (2021–2021)Lei Liang · Zhejiang Provincial People's Hospital3 papers (2021–2021)Feng Shen · Qingdao University2 papers (2021–2021)Wan Yee Lau · Army Medical University2 papers (2021–2021)Jian‐Feng Tu · Beijing University of Chinese Medicine2 papers (2017–2017) · 2 papers (2021–2021)Lijie Li · Shanghai Medical College of Fudan University2 papers (2017–2017)Liu Yang · Mudanjiang Medical University2 papers (2017–2017)Tian Yang · Nanchang University2 papers (2021–2021)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cancer Research · Molecular Biology →